Suzhou-based Innovent Biologics saw its obesity drug, Mazdutide, approved by Chinese regulators last yearand according to a 2025 report released by LEK Consulting, China has more than 60 obesity drug candidates under development that are set to compete with those produced in the United States
Two molecules, GHK and securinine topped the list and were selected out of 1,309 bioactive molecules as the best agents capable to reverse expression of 54 gene sets overexpressed in malignant invasive metastatic colon cancer, which included node molecules YWHAB, MAP3K5, LMNA, APP, GNAQ, F3, NFATC2, and TGM2, involved in regulation of multiple biochemical pathways [ 27 ]
We are not treating your medical conditions
From physician-grade nutraceutical access to private labeling, pharmacy partnerships, and marketing support, everything is built to work together not in pieces
Dont chug, sip steadily throughout the day